Voyager Therapeutics, INC. (VYGR) — DEF 14A Filings
All DEF 14A filings from Voyager Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Voyager Therapeutics Files 2025 Proxy Statement
— Apr 23, 2025 Risk: medium
Voyager Therapeutics, Inc. filed its DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2025. The filing details executive compensation, includi -
Voyager Therapeutics Announces 2024 Annual Meeting of Stockholders on June 5
— Apr 25, 2024 Risk: low
Voyager Therapeutics, Inc. (VYGR) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Voyager Therapeutics will hold its 2024 Annual Meeting of St
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX